Role of NMDA receptors in the pathophysiology and treatment of status epilepticus

34Citations
Citations of this article
108Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

This review considers the role of N-methyl-d-aspartate receptors in the pathophysiology and treatment of status epilepticus (SE). NMDA receptors play a critical role in sustaining SE by mediating the plasticity of γ-aminobutyric acid (GABA)-A and α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors, neuronal loss, and epileptogenesis. In parallel, there is growing interest in using the NMDA receptor antagonist ketamine in the treatment of refractory SE. Ketamine has proved to be safe for use in refractory and super-refractory SE in patients. The pilot studies also suggest that ketamine may be efficacious for termination of refractory SE.

Author supplied keywords

Cite

CITATION STYLE

APA

Kapur, J. (2018). Role of NMDA receptors in the pathophysiology and treatment of status epilepticus. Epilepsia Open, 3(S2), 165–168. https://doi.org/10.1002/epi4.12270

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free